What Enantyum Treats: Main Uses and Benefits

Enantyum (dexketoprofen) is a medication primarily used in situations involving certain distressing symptoms related to discomfort. Its main purpose is relevant when supportive symptom management is appropriate for symptoms that create noticeable physiological strain. This medication is relevant for easing symptoms associated with acute or episodic changes.

The medication is commonly used to help with symptom clusters that may become intense or disruptive, covering conditions presenting with systemic or localized discomfort, such as acute musculo-skeletal pain, painful periods (dysmenorrhoea), and dental pain.

This approach contributes to easing the overall symptom load during periods of heightened symptoms. This supports the patient during difficult episodes by easing distress. The approach is commonly used across conditions presenting with acute episodes, which may assist with helping patients cope more steadily with symptom fluctuations.

---

“It may assist with maintaining functional stability when symptoms interfere with routine activities.”

---

Quick Fact: May assist with Acute Pain

Regulatory References

1. Summary of Product Characteristics (HPRA)

Eligibility Map: Who can and cannot use Enantyum

Enantyum (dexketoprofen) is indicated for use in adult patients (18 years and older).

Contraindications (Must Not Use)

Use of Enantyum is strictly prohibited for numerous groups based on official regulatory documents. These include:

• Patients with known allergies to dexketoprofen, other non-steroidal anti-inflammatory drugs (NSAIDs), or those who experience asthma, angioedema, or acute rhinitis after taking NSAIDs.
• Individuals with an active peptic ulcer/gastrointestinal hemorrhage or a history of recurrent ulceration or bleeding related to prior NSAID use.
• Patients with severe heart failure, moderate-to-severe renal dysfunction (creatinine clearance leq 59 mL/ min), or severe hepatic impairment.
• Individuals with Crohn’s disease or ulcerative colitis, a bleeding disorder, or severe dehydration.
• Children and adolescents (under 18 years) due to lack of established safety and efficacy data.
• Women in the third trimester of pregnancy and those who are breast-feeding.

Restricted or Special Consideration

Special caution and/or dose reduction are required for:

• Elderly patients, who should start treatment at the lowest recommended daily dose (e.g., 50 mg total daily dose).
• Patients with mild renal or mild to moderate hepatic impairment, who require a reduced starting dose and close medical supervision.
• Women who are planning to become pregnant, as the medicine may potentially impair female fertility.

Interactions with other medicines and products

Regulatory authorities classify specific combinations with Enantyum (Dexketoprofen) based on the potential for augmented risk, primarily due to its nature as a Non-Steroidal Anti-Inflammatory Drug (NSAID).

Contraindicated Combinations

Co-administration with other NSAIDs, including COX-2 selective inhibitors, is prohibited. This restriction also applies to Acetylsalicylic acid (Aspirin) when used at analgesic or anti-inflammatory doses.

---

Documented Pharmacodynamic and Exposure-Altering Interactions

Interactions are documented with substances that affect haemostasis or clearance:

• Anticoagulants (e.g., Warfarin, Heparins): Not recommended due to an officially documented increased risk of bleeding.
• Oral Corticosteroids and SSRIs: Concurrent use may increase the risk of gastrointestinal ulceration and bleeding.
• Lithium: Dexketoprofen may increase the plasma levels of Lithium, requiring caution and potential monitoring of the co-administered drug.
• Methotrexate: The drug can reduce the clearance of Methotrexate, increasing its toxicity. The use with high doses of Methotrexate is generally inadvisable.

Other Interaction Considerations

Taking the tablets with food can slow the rate of absorption but may help decrease the potential for gastrointestinal side effects. Elderly patients are officially noted to have a higher frequency of serious gastrointestinal reactions when taking NSAIDs.

Dexketoprofen is a non-steroidal anti-inflammatory drug (NSAID) that exerts its primary pharmacodynamic effect by inhibiting the activity of the cyclooxygenase (COX) enzyme system. This system is crucial for converting arachidonic acid into various prostanoids, including prostaglandins, thromboxanes, and prostacyclins.

Mechanistically, dexketoprofen preferentially targets the cyclooxygenase-2 (COX-2) isoform. COX-2 is the inducible form of the enzyme, often upregulated at sites of cellular stress. By non-covalently binding to the COX-2 active site, dexketoprofen competitively inhibits the catalytic conversion of the fatty acid precursor.

This targeted inhibition leads to a rapid and sustained reduction in the biosynthesis of prostanoids within peripheral tissues and the central nervous system. These lipid compounds function as crucial local chemical mediators, facilitating both inflammation and the transmission of nociception signaling. The resulting systemic modulation of the eicosanoid cascade is the singular basis for the drug's effects.

Instruction Map: How to use Enantyum — Official Administration Guidelines

The administration of Enantyum (dexketoprofen trometamol) follows a protocol defined by routes, dose thresholds, timing relative to food intake, and maximum duration of use.

Feature	Guideline
Route of Administration	Oral (film-coated tablets, granules, solution) and Parenteral (intramuscular or intravenous bolus/infusion).
Dosing Schedule (Maximum Doses)	Oral: 12.5 mg every 4–6 hours or 25 mg every 8 hours. Total daily intake must not exceed 75 mg. Parenteral: 50 mg every 8–12 hours. Total daily intake must not exceed 150 mg.
Timing in relation to meals	For faster action, oral administration is recommended at least 30 minutes before meals (tablets) or 15 minutes before meals (granules/oral solution).
Preparation Requirements	Granules/Oral Solution: Must be dissolved or stirred in water and ingested immediately. IV Infusion: Requires prior dilution and must be protected from natural daylight.
Age-group administration rules	Older Adults & Impairment: Initial dose must be reduced to a maximum of 50 mg total daily dose for older adults and patients with mild hepatic or renal impairment. Pediatric: Not established as safe or effective, and the product is not to be used in children and adolescents.

---

Instruction Classifications (High-Level)

Classification	Official Pattern
Administration method type	Oral / Intramuscular / Intravenous
Frequency pattern	As-needed (on demand for symptoms) with minimum time intervals (e.g., 4, 6, 8, or 12 hours)
Use-context constraints	Duration-limited (e.g., max 2 days for IV) and Time-dependent (must be taken before meals for fast action).

---

Resulting Procedural Structure

The administration protocol is based on defined dose limits and procedural timing. The medicine is intended for short-term use only, and treatment duration must be limited to the symptomatic period. For the injectable form, the maximum duration is two days, requiring a switch to an oral analgesic when feasible. Intravenous administration requires specific procedural steps, such as administering a bolus over no less than 15 seconds.

Research Evidence / Overview of Studies for Enantyum

The clinical evaluation of Enantyum (dexketoprofen trometamol) has focused primarily on its use in research scenarios examining short-term or episodic symptom patterns. The evidence base relies heavily on high-quality studies, including randomized controlled trials (RCTs) and comprehensive systematic reviews, which contribute to the broader evidence landscape by examining outcomes related to physical discomfort.

---

Evidence for Use in Acute Postoperative Pain

This section summarizes the structure of short-term Randomized Controlled Trials (RCTs) and meta-analyses that examined the measured outcomes related to pain intensity and the need for rescue medication following surgical procedures. Research has explored the compound in settings of acute pain and monitored outcomes related to physical discomfort. Studies recorded measurements over the initial few hours following a single dose. Data show patterns related to the speed of onset of symptom change and the duration of the measured outcomes related to physical discomfort. The evidence base provides limited information regarding patients with certain comorbidities or those outside the standard adult age range, as these groups were often excluded.

---

Evidence for Use in Acute Musculoskeletal Pain

Dexketoprofen was studied for conditions involving periods of heightened symptoms such as acute low back pain, sprains, and strains. Research explored outcomes linked to inflammatory or irritative states, as well as outcomes reflecting daily functioning or activity level. The studies monitored pain intensity using standardized scales, and data show patterns related to symptom intensity or variability over the short treatment periods (e.g., 3 to 5 days). The comparative evidence against other similar compounds is limited or mixed across specific acute pain categories.

---

What is Still Uncertain About the Research

A primary research limitation is that the trials were mostly designed to track short-term or episodic symptom patterns. As a result, long-term effects are not fully established, and there is limited evidence for its effects on conditions where symptoms may vary in intensity over many months. Furthermore, the data for certain groups remain insufficient because specific patient populations—including older adults, children, and those with significant chronic health issues—were generally not included in the primary efficacy studies.

Common questions about Enantyum (FAQ)

---

Q: What should I do if I miss a dose of Enantyum?

Official administration instructions state that if a dose is missed, the patient should skip the forgotten dose and take the next dose at the usual time. Regulatory labeling states that a patient should not take a double dose to make up for a missed one.

---

Q: How long does it take for Enantyum to start working after taking it?

Studies and official product information indicate that the active ingredient is quickly absorbed. The time to reach maximum concentration is reported to be rapid, generally within the initial hour after oral administration. For fastest action, it is often recommended to take the medication before meals.

---

Q: Can I drink alcohol while taking Enantyum?

Regulatory labeling notes that consuming alcohol while taking this medication may potentiate side effects such as dizziness or drowsiness. Official labeling notes that the combination may affect your ability to drive or operate machinery, and it should be used with awareness of this potential.

---

Q: How long is it safe to take Enantyum? Is it for long-term use?

The use of this medication is authorized for short-term use only, and the duration of treatment must be limited strictly to the symptomatic period. Regulatory guidance suggests that undesirable effects may be reduced by using the lowest effective dose for the shortest treatment period necessary.

---

Q: Is there a specific antidote for a dexketoprofen overdose?

Official regulatory documents state that no specific antidote has been established for an overdose of this medication. Management includes symptomatic treatment and supportive care, with procedures such as gastric lavage or activated charcoal possibly being considered.

---

Q: Is this an over-the-counter (OTC) medicine or is it prescription-only in my country?

Regulatory records from various jurisdictions classify most formulations of this product as a Prescription Drug (Rx). The legal status can vary depending on the specific formulation and the local regulatory authority in your region.

---

Q: What should I do if I accidentally take two tablets at once?

Regulatory guidance advises contacting a physician or poison control center immediately after an accidental ingestion. This allows for appropriate assessment and supportive care, as symptoms of overdose can sometimes be delayed.

---

Q: How should I dispose of expired Enantyum tablets?

Any unused or expired medicine must be disposed of correctly according to local requirements. Official guidelines state that medication should not be disposed of via household waste or wastewater; it should be returned to a designated pharmaceutical collection point.

---

Q: Is it okay to crush the tablets if I have trouble swallowing them?

Official administration information states the film-coated tablet should be swallowed whole with a sufficient amount of liquid. While some tablets may be scored for division, the product information does not include directions for crushing the entire tablet for administration.

How to Store and Dispose of Enantyum (Dexketoprofen)

Official regulatory guidelines define specific storage and disposal requirements for Enantyum film-coated tablets to ensure stability and environmental safety.

---

Storage Requirements

• Temperature and Light: The medicine must be stored at a temperature not exceeding 30, C (86, F). The blister must be kept in the original outer carton to protect the tablets from light.
• Child Safety: Like all medications, Enantyum must be kept out of the sight and reach of children.

---

Disposal Instructions

Unused or expired product should be handled according to local requirements. It is essential not to throw away any medicines via wastewater or household waste; instead, they should be returned to a local pharmaceutical collection point to help protect the environment.